Athena study roche cobas hpv

ATHENA HPV Trial Background & Study Design | cobas® HPV Test

★ ★ ★ ☆ ☆

ATHENA HPV trial unique study design The ATHENA HPV trial was a large, prospective clinical study evaluating the performance of the cobas ® HPV Test in three relevant populations: women with ASC-US cervical cytology, women with normal cervical cytology, and an overall screening population (25+ years) to explore HPV as a first-line test (ongoing longitudinal 3 year study).

ATHENA HPV Trial Background & Study Design | cobas® HPV Test

Study Validates cobas® HPV Test - diagnostics.roche.com

★ ★ ☆ ☆ ☆

The Roche ATHENA study for the cobas HPV Test is the largest U.S.-based registration study for cervical cancer screening, including more than 47,000 women. The study is designed to answer current medical and scientific questions about the importance of testing for high-risk HPV genotypes in cervical cancer screening and to provide clinical ...

Study Validates cobas® HPV Test - diagnostics.roche.com

ATHENA Data Back HPV Test - diagnostics.roche.com

★ ★ ★ ★ ★

The Roche ATHENA study for the cobas HPV Test is the largest U.S.-based registration study for cervical cancer screening, including more than 47,000 women. The study is designed to answer current medical and scientific questions about the importance of testing for high-risk HPV genotypes in cervical cancer screening and to provide clinical ...

ATHENA Data Back HPV Test - diagnostics.roche.com

Roche - Pivotal Study Validates Roche’s cobas® HPV Test ...

★ ★ ★ ★ ☆

About the cobas HPV Test . As demonstrated in the ATHENA trial, Roche’s cobas HPV Test is the only HPV test under investigation in the U.S. that simultaneously detects 12 high-risk HPV types (HPV types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) as a pooled …

Roche - Pivotal Study Validates Roche’s cobas® HPV Test ...

Primary cervical cancer screening with human ...

★ ★ ★ ★ ☆

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test☆ Thomas C. Wrighta,⁎, Mark H. Stolerb, Catherine M. Behrensc, Abha Sharmac, Guili Zhangc, Teresa L. Wrightd a Department of Pathology and Cell Biology, Columbia University, New York, NY, USA

Primary cervical cancer screening with human ...

Primary cervical cancer screening with human ...

★ ★ ★ ★ ★

OBJECTIVES: ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer in women ≥25years. This reports the 3-year end-of-study results comparing the performance of HPV primary screening to different screening and triage combinations. METHODS: 42,209 women ≥25years were enrolled and had cytology and hrHPV testing.

Primary cervical cancer screening with human ...

ATHENA HPV Clinical Trial Overview | cobas® HPV Test

★ ★ ★ ☆ ☆

ATHENA HPV trial overview. The cobas ® HPV Test was clinically validated by the landmark ATHENA trial, a large, prospective clinical study that evaluated the test’s performance in three relevant populations:* 1. Women with ASC-US cervical cytology (21+ years) Women with normal cervical cytology (30+ years) Overall screening population (25+ years) to explore HPV as a first-line test

ATHENA HPV Clinical Trial Overview | cobas® HPV Test

ATHENA HPV Clinical Trial Overview | cobas® HPV Test

★ ★ ★ ☆ ☆

ATHENA HPV trial overview. The cobas ® 4800 HPV Test was clinically validated by the landmark ATHENA trial, the largest-ever U.S.-based registration study for cervical cancer screening. It validated the test for: Reflex testing of atypical squamous cells of undetermined significance (ASC-US) cytology

ATHENA HPV Clinical Trial Overview | cobas® HPV Test

The ATHENA human papillomavirus study: design, methods ...

★ ★ ★ ★ ☆

The ATHENA human papillomavirus study: design, methods, and baseline results ... all HPV results are based on the second-generation Roche HPV test (cobas HPV Test). The primary study endpoint for disease detection was high-grade cervical disease defined as CIN2 or greater (CIN2, CIN3, adenocarcinoma in situ, and invasive cervical cancer), as ...

The ATHENA human papillomavirus study: design, methods ...

Roche - A New Study Shows that Testing for HPV Genotypes ...

★ ★ ★ ★ ★

Investor Update. Basel, 08 July 2010. A New Study Shows that Testing for HPV Genotypes 16 and 18 Detects Cervical Pre-Cancer Missed by Pap Test. 1 in 10 women in the ATHENA trial, age 30-years and older, who tested positive for HPV genotypes 16 and/or 18 by the cobas® 4800 HPV Test had cervical pre-cancer, although their Pap test was normal.

Roche - A New Study Shows that Testing for HPV Genotypes ...

ATHENA infographic package | Roche Women's Health

★ ★ ★ ★ ★

To better determine who is most at risk of developing cervical cancer, Roche has developed the cobas® HPV Test, which was evaluated in the ATHENA HPV trial. This clinical study involved over 47,000 women in three relevant populations. The trial validated the cobas® HPV Test as comparable to the current standard of hrHPV testing, and at the ...

ATHENA infographic package | Roche Women's Health

ATHENA HPV Studie Übersicht - hpv-roche.at

★ ★ ★ ★ ★

Referenzen: 1. cobas ® 4800 HPV Test US package insert. April 2011. 2. Stoler MH, Wright TC, Sharma A, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135(3):468-475. 3. Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens CM, Wright TL.Evaluation of HPV-16 and HPV-18 genotyping for the triage of …

ATHENA HPV Studie Übersicht - hpv-roche.at

cobas® HPV Test von Roche | HPV 16 und HPV 18 …

★ ★ ★ ☆ ☆

Der cobas® HPV Test liefert ein Gesamt-hrHPV-Testergebnis mit individueller HPV 16 und 18 Genotypisierung, was Gynäkologen beim Folgen von Leitlinien im Zervixkarzinom-Screening hilft.

cobas® HPV Test von Roche | HPV 16 und HPV 18 …

Primary cervical cancer screening with human ...

★ ★ ★ ★ ☆

Objectives. ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer in women ≥ 25 years.This reports the 3-year end-of-study results comparing the performance of HPV primary screening to different screening and triage combinations.

Primary cervical cancer screening with human ...

Evaluation of the Cobas 4800 HPV Test for Detecting High ...

★ ★ ★ ★ ★

9/12/2012 · The ATHENA HPV study and several smaller studies have compared the Cobas test with the Hybrid Capture 2 assay [7,8,9]. However, no studies have been published to date comparing the Cobas 4800 assay to the Invader technology. In this study, we evaluated analytical performance and interassay agreement between these two tests.

Evaluation of the Cobas 4800 HPV Test for Detecting High ...

Estudio HPV - Prueba cobas® HPV de Roche

★ ★ ★ ★ ☆

Resumen de hallazgos clave. La Prueba cobas ® HPV Test fue clínicamente validada en el estudio ATHENA, el primer estudio para el registro que evaluó simultáneamente y en tiempo real la genotipificación de 12 genotipos de alto riesgo de Virus de Papiloma Humano (hrHPV, por sus siglas en inglés), además del VPH 16 y VPH 18 de manera individual.

Estudio HPV - Prueba cobas® HPV de Roche

Roche - Roche Diagnostics receives Health Canada ...

★ ★ ☆ ☆ ☆

1/31/2019 · As demonstrated by the prospective clinical study “ATHENA 2 ” comparing screening strategies using cobas ® HPV test on the cobas ® 4800 System, screening with the HPV test detects more high-grade disease than a Pap test alone. Identifying women at risk, before pre-cancer or cancer develops, is an important prevention strategy as it helps ...

Roche - Roche Diagnostics receives Health Canada ...

Evaluation of the Cobas® 4800 HPV Test for the Detection ...

★ ★ ☆ ☆ ☆

7/3/2008 · Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.

Evaluation of the Cobas® 4800 HPV Test for the Detection ...

ATHENA Publication Press Release Final - cobas® HPV Test ...

★ ★ ☆ ☆ ☆

The Roche ATHENA study for the cobas ® HPV Test is the largest U.S.-based registration study for cervical cancer screening, including more than 47,000 women. The study is designed to answer current medical and scientific questions about the importance of testing for high-risk HPV genotypes in cervical cancer screening and to provide clinical ...

ATHENA Publication Press Release Final - cobas® HPV Test ...

cobas HPV - YouTube

★ ★ ★ ☆ ☆

Roche Molecular Systems is a leader in research-focused healthcare. We are committed to innovating healthcare with products and services that help our custom...

cobas HPV - YouTube

Clinical Validation of the cobas HPV Test on the cobas ...

★ ★ ★ ★ ☆

2/1/2019 · This study demonstrates that the clinical sensitivity, specificity, and reproducibility of the novel cobas human papillomavirus (HPV) test on the cobas 6800 system for high-risk HPV types fulfills the criteria for use in population-based cervical screening. The criteria were formulated by an international consortium, using the cobas 4800 HPV test as a validated reference assay.

Clinical Validation of the cobas HPV Test on the cobas ...
Pleacher-bible-study.html,Poetics-of-space-study-guide.html,Police-test-study-guide.html,Polysystem-theory-case-study.html,Ponemon-institute-benchmark-study.html